RedHill Biopharma Ltd. ("RDHL") Corporate Presentation September 2019 Disclaimer and Forward Looking Statements No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no representation or warranty is given, and the Company has no responsibility, as to the achievement or reasonableness of any forecasts, estimates, or statements as to prospects contained or referred to in th ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q2 2019 Earnings Conference Call July 23, 2019 8:30 AM ET Company Participants Guy Goldberg - Chief Business Officer Dror Ben-Asher - Chief Executive Officer Micha Ben-Chorin - Chief Financial Officer Gilead Raday - Chief Operating Officer Rick Scruggs - Chief Operating Officer, U.S. Operations Conference Call Participants Christopher Marai - Nomura Matt Kaplan - Ladenburg Thalmann Scott Henry - Roth Capital Steve Brozak - WBB Robin Garner - LifeSci Capital Ed Woo - Asce ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Alexandra Okmian - Investor Relations Dror Ben-Asher - Chief Executive Officer Micha Ben Chorin - Chief Financial Officer Gilead Raday - Chief Operating Officer Guy Goldberg - Chief Business Officer Conference Call Participants Christopher Marai – Nomura | Instinet Stephen Brozak - WBB Securities, LLC Matthew Kaplan - Ladenburg Thalmann & Co. Inc. Jonas Peciulis - Edison Investment Research Edwa ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation April 2019 Disclaimer and Forward Looking Statements No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no representation or warranty is given, and the Company has no responsibility, as to the achievement or reasonableness of any forecasts, estimates, or statements as to prospects contained or referred to in this p ...

RedHill Biopharma Ltd. ("RDHL") Corporate Presentation March 2019 Disclaimer and Forward Looking Statements No representation or warranty is made to the accuracy or completeness of this presentation. You must make your own investigation and assessment of the matters contained herein. In particular, no representation or warranty is given, and the Company has no responsibility, as to the achievement or reasonableness of any forecasts, estimates, or statements as to prospects contained or referred to in this p ...

RedHill Biopharma Ltd. (NASDAQ:RDHL) Q4 2018 Earnings Conference Call February 26, 2019 8:30 AM ET Â Company Participants Dror Ben-Asher – Chief Executive Officer Micha Ben Chorin – Chief Financial Officer Gilead Raday – Chief Operating Officer Conference Call Participants Allen Cha – Nomura Scott Henry – Roth Capital Steve Brozak – WBB Securities Matt Kaplan – Ladenburg Swayampakula Ramakanth – H.C.Wainwright Robin Garner – LifeSci Capital Jonas Peciulis – Edison Ed Woo – Ascendiant Capital Operator [Call ...